Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride improves hair density and thickness in women with hair loss.

SHBG may be a useful early indicator and treatment target for PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Progesterone boosts alcohol's effect on brain, finasteride counters it.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Hair loss in postmenopausal woman caused by ovarian issue.

Aromatherapy uses essential oils to improve mood and well-being.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.